Pyxis Oncology, Inc. (PYXS)
Pyxis Oncology, Inc. (PYXS)
| Financial Ratios | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 |
|---|---|---|---|---|
| Return on Equity | -74.597 | -33.931 | -31.883 | -21.003 |
| Net Profit Margin | - | -164.178 | - | -652.766 |
| Debt to Asset Ratio | 51.372 | 41.643 | 34.871 | 28.87 |
| Cash Ratio | 34.878 | 72.983 | 46.017 | 60.714 |
| Quick Ratio | 275.659 | 341.229 | 428.609 | 565.426 |
| Current Ratio | 275.659 | 341.229 | 428.609 | 565.426 |